Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04165317
Brief Title: Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST)

First Submitted : November 13, 2019
First Submitted that Met QC Criteria : November 13, 2019
First Posted : November 15, 2019

Last Update Submitted that Met QC Criteria : June 29, 2021
Last Update Posted : July 1, 2021